Micropaque Scanner (Barium Sulfate)

Barium sulfate, the active ingredient in Micropaque Scanner, is a contrast media presented as an oral suspension for gastrointestinal imaging. It creates a radiopaque coating that enhances X‑ray visualization of the esophagus, stomach, duodenum and colon during diagnostic procedures.

GNH USA supplies Micropaque Scanner as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards. The company provides reliable sourcing, quality assurance and logistics support for diagnostic radiology agents across multiple markets.

Micropaque Scanner, a barium sulfate suspension, provides radiopaque contrast for gastrointestinal imaging procedures. - Barium swallow (esophageal imaging): enables clear visualization of the esophageal lumen and motility. - Barium meal (stomach and duodenal imaging): delineates gastric and duodenal mucosa for assessment of ulcers, masses, and motility. - Barium enema (colon imaging): outlines the colon to detect polyps, strictures, and inflammatory changes.

Oral barium sulfate suspensions are generally well tolerated, but they may cause a range of gastrointestinal and systemic reactions.

Common Side Effects: - Nausea: mild to moderate nausea may occur during or after ingestion. - Abdominal discomfort: cramping or bloating is reported by some patients. - Constipation: temporary slowdown of bowel movements may be experienced. - Diarrhea: loose stools can occur, especially with high-volume preparations. - Metallic taste: a transient metallic sensation in the mouth may be noted.

Serious or Rare Side Effects: - Aspiration pneumonia: inhalation of the suspension can lead to lung infection. - Barium impaction: severe constipation may cause blockage of the bowel. - Allergic reaction: rare hypersensitivity presenting with rash, itching or swelling. - Peritonitis: leakage of barium into the peritoneal cavity after perforation. - Electrolyte imbalance: large volumes may affect electrolyte levels in vulnerable patients.

Before using Micropaque Scanner, clinicians should assess patient suitability and follow specific safety measures. - Assess gastrointestinal integrity: avoid use in patients with known or suspected perforation, obstruction or severe dysphagia. - Review allergy history: contraindicated in individuals with documented hypersensitivity to barium sulfate. - Evaluate renal function: caution in patients with severe renal impairment due to potential fluid shifts. - Consider pregnancy status: use only if clearly needed, as safety data are limited. - Monitor for aspiration risk: ensure proper positioning and swallowing ability during administration. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Barium sulfate may interact with certain medications or substances that affect gastrointestinal motility or absorption.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: can bind barium and reduce imaging quality. - Iron supplements: may cause precipitation and interfere with contrast visualization.

Moderate Interactions (Monitor Closely): - Laxatives: may alter transit time, affecting coating uniformity. - Prokinetic agents: increased motility can reduce contact time of barium with mucosa. - Oral contrast agents (iodinated): concurrent use may complicate image interpretation.